Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 240

1.

Should patients with pulmonary hypertension fly and climb?

Kovacs G, Olschewski H.

Int J Cardiol. 2018 Jul 12. pii: S0167-5273(18)33615-5. doi: 10.1016/j.ijcard.2018.07.054. [Epub ahead of print] No abstract available.

PMID:
30031623
2.

Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach.

Odler B, Foris V, Gungl A, Müller V, Hassoun PM, Kwapiszewska G, Olschewski H, Kovacs G.

Front Physiol. 2018 Jun 19;9:587. doi: 10.3389/fphys.2018.00587. eCollection 2018. Review.

3.

Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension.

Fazakas C, Nagaraj C, Zabini D, Végh AG, Marsh LM, Wilhelm I, Krizbai IA, Olschewski H, Olschewski A, Bálint Z.

Front Physiol. 2018 May 15;9:537. doi: 10.3389/fphys.2018.00537. eCollection 2018.

4.

The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells.

Leithner K, Triebl A, Trötzmüller M, Hinteregger B, Leko P, Wieser BI, Grasmann G, Bertsch AL, Züllig T, Stacher E, Valli A, Prassl R, Olschewski A, Harris AL, Köfeler HC, Olschewski H, Hrzenjak A.

Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6225-6230. doi: 10.1073/pnas.1719871115. Epub 2018 May 29.

5.

Healthy Lung Vessel Morphology Derived From Thoracic Computed Tomography.

Pienn M, Burgard C, Payer C, Avian A, Urschler M, Stollberger R, Olschewski A, Olschewski H, Johnson T, Meinel FG, Bálint Z.

Front Physiol. 2018 Apr 10;9:346. doi: 10.3389/fphys.2018.00346. eCollection 2018.

6.

Pulmonary Vascular Involvement in COPD - Is There a Pulmonary Vascular Phenotype?

Kovacs G, Agusti A, Barberà JA, Celli B, Criner G, Humbert M, Sin DD, Voelkel N, Olschewski H.

Am J Respir Crit Care Med. 2018 May 10. doi: 10.1164/rccm.201801-0095PP. [Epub ahead of print]

PMID:
29746142
7.

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.

Gräf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Aldred M, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, MacKenzie Ross RV, Moledina S, Montani D, Newnham M, Olschewski A, Olschewski H, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Stein DF, Suntharalingam J, Swietlik EM, Toshner MR, van Heel DA, Vonk Noordegraaf A, Waisfisz Q, Wharton J, Wort SJ, Ouwehand WH, Soranzo N, Lawrie A, Upton PD, Wilkins MR, Trembath RC, Morrell NW.

Nat Commun. 2018 Apr 12;9(1):1416. doi: 10.1038/s41467-018-03672-4.

8.

Pulmonary capillary recruitment in exercise and pulmonary hypertension.

Olschewski H, Kovacs G, Herve P.

Eur Respir J. 2018 Mar 15;51(3). pii: 1800260. doi: 10.1183/13993003.00260-2018. Print 2018 Mar. No abstract available.

PMID:
29545320
9.

Network Analysis to Risk Stratify Patients With Exercise Intolerance.

Oldham WM, Oliveira RKF, Wang RS, Opotowsky AR, Rubins DM, Hainer J, Wertheim BM, Alba GA, Choudhary G, Tornyos A, MacRae CA, Loscalzo J, Leopold JA, Waxman AB, Olschewski H, Kovacs G, Systrom DM, Maron BA.

Circ Res. 2018 Mar 16;122(6):864-876. doi: 10.1161/CIRCRESAHA.117.312482. Epub 2018 Feb 5.

PMID:
29437835
10.

MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas.

Fadejeva I, Olschewski H, Hrzenjak A.

Oncotarget. 2017 Dec 5;8(70):115754-115773. doi: 10.18632/oncotarget.22975. eCollection 2017 Dec 29. Review.

11.

The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension.

Marsh LM, Jandl K, Grünig G, Foris V, Bashir M, Ghanim B, Klepetko W, Olschewski H, Olschewski A, Kwapiszewska G.

Eur Respir J. 2018 Jan 25;51(1). pii: 1701214. doi: 10.1183/13993003.01214-2017. Print 2018 Jan.

PMID:
29371380
12.

Resident cell lineages are preserved in pulmonary vascular remodeling.

Crnkovic S, Marsh LM, El Agha E, Voswinckel R, Ghanim B, Klepetko W, Stacher-Priehse E, Olschewski H, Bloch W, Bellusci S, Olschewski A, Kwapiszewska G.

J Pathol. 2018 Apr;244(4):485-498. doi: 10.1002/path.5044. Epub 2018 Mar 9.

13.

No erythropoietin-induced growth is observed in non-small cell lung cancer cells.

Frille A, Leithner K, Olschewski A, Olschewski H, Wohlkönig C, Hrzenjak A.

Int J Oncol. 2018 Feb;52(2):518-526. doi: 10.3892/ijo.2017.4225. Epub 2017 Dec 12.

PMID:
29345289
14.

Right ventricular fibrosis and dysfunction: Actual concepts and common misconceptions.

Egemnazarov B, Crnkovic S, Nagy BM, Olschewski H, Kwapiszewska G.

Matrix Biol. 2018 Aug;68-69:507-521. doi: 10.1016/j.matbio.2018.01.010. Epub 2018 Jan 16. Review.

PMID:
29343458
15.

An official European Respiratory Society statement: pulmonary haemodynamics during exercise.

Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, Garcia G, Grünig E, Howard L, Humbert M, Lau E, Laveneziana P, Lewis GD, Naeije R, Peacock A, Rosenkranz S, Saggar R, Ulrich S, Vizza D, Vonk Noordegraaf A, Olschewski H.

Eur Respir J. 2017 Nov 22;50(5). pii: 1700578. doi: 10.1183/13993003.00578-2017. Print 2017 Nov. Erratum in: Eur Respir J. 2018 Jan 18;51(1):.

PMID:
29167297
16.

Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality.

Douschan P, Kovacs G, Avian A, Foris V, Gruber F, Olschewski A, Olschewski H.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):509-516. doi: 10.1164/rccm.201706-1215OC.

PMID:
29099619
17.

Understanding exercise hemodynamics.

Olschewski H.

Pulm Circ. 2017 Jul-Sep;7(3):565-566. doi: 10.1177/2045893217728694. No abstract available.

18.

TR3 is involved in hypoxia-induced apoptosis resistance in lung cancer cells downstream of HIF-1α.

Wohlkoenig C, Leithner K, Olschewski A, Olschewski H, Hrzenjak A.

Lung Cancer. 2017 Sep;111:15-22. doi: 10.1016/j.lungcan.2017.06.013. Epub 2017 Jun 21.

PMID:
28838387
19.

Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox.

Nagaraj C, Tabeling C, Nagy BM, Jain PP, Marsh LM, Papp R, Pienn M, Witzenrath M, Ghanim B, Klepetko W, Weir EK, Heschl S, Kwapiszewska G, Olschewski A, Olschewski H.

Eur Respir J. 2017 Jul 20;50(1). pii: 1601651. doi: 10.1183/13993003.01651-2016. Print 2017 Jul.

PMID:
28729471
20.

Changes in pulmonary exercise haemodynamics in scleroderma: a 4-year prospective study.

Kovacs G, Avian A, Wutte N, Hafner F, Moazedi-Fürst F, Kielhauser S, Aberer E, Brodmann M, Graninger W, Foris V, Olschewski A, Olschewski H.

Eur Respir J. 2017 Jul 13;50(1). pii: 1601708. doi: 10.1183/13993003.01708-2016. Print 2017 Jul.

PMID:
28705939
21.

Importance of kynurenine in pulmonary hypertension.

Nagy BM, Nagaraj C, Meinitzer A, Sharma N, Papp R, Foris V, Ghanim B, Kwapiszewska G, Kovacs G, Klepetko W, Pieber TR, Mangge H, Olschewski H, Olschewski A.

Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L741-L751. doi: 10.1152/ajplung.00517.2016. Epub 2017 Jul 13.

PMID:
28705908
22.

The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension.

Gessler T, Ghofrani HA, Held M, Klose H, Leuchte H, Olschewski H, Rosenkranz S, Fels L, Li N, Ren D, Kaiser A, Schultze-Mosgau MH, Müllinger B, Rohde B, Seeger W.

Pulm Circ. 2017 Apr-Jun;7(2):505-513. doi: 10.1177/2045893217706691. Epub 2017 May 12.

23.

Lack of ABCG2 Leads to Biventricular Dysfunction and Remodeling in Response to Hypoxia.

Nagy BM, Nagaraj C, Egemnazarov B, Kwapiszewska G, Stauber RE, Avian A, Olschewski H, Olschewski A.

Front Physiol. 2017 Feb 21;8:98. doi: 10.3389/fphys.2017.00098. eCollection 2017.

24.

Pulmonary Hypertension.

Hoeper MM, Ghofrani HA, Grünig E, Klose H, Olschewski H, Rosenkranz S.

Dtsch Arztebl Int. 2017 Feb 3;114(5):73-84. doi: 10.3238/arztebl.2017.0073.

25.

Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis.

Dumitrescu D, Nagel C, Kovacs G, Bollmann T, Halank M, Winkler J, Hellmich M, Grünig E, Olschewski H, Ewert R, Rosenkranz S.

Heart. 2017 May;103(10):774-782. doi: 10.1136/heartjnl-2016-309981. Epub 2017 Jan 6.

PMID:
28062514
26.

Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension.

Kovacs G, Avian A, Foris V, Tscherner M, Kqiku X, Douschan P, Bachmaier G, Olschewski A, Matucci-Cerinic M, Olschewski H.

PLoS One. 2016 Dec 28;11(12):e0168706. doi: 10.1371/journal.pone.0168706. eCollection 2016.

27.

[ESC guidelines 2015 pulmonary hypertension: diagnosis and treatment].

Opitz C, Rosenkranz S, Ghofrani HA, Grünig E, Klose H, Olschewski H, Hoeper M.

Dtsch Med Wochenschr. 2016 Nov;141(24):1764-1769. Epub 2016 Nov 30. German.

PMID:
27903027
28.

[Pulmonary Hypertension: Cologne Consensus Conference 2016].

Rosenkranz S, Ghofrani HA, Grünig E, Klose H, Olschewski H, Opitz C, Hoeper M.

Dtsch Med Wochenschr. 2016 Nov;141(24):1778-1782. Epub 2016 Nov 8. Review. German.

PMID:
27825176
29.

[Pulmonary hypertension due to chronic lung disease: Recommendations of the Cologne Consensus Conference 2016].

Olschewski H, Behr J, Bremer H, Claussen M, Douschan P, Halank M, Held M, Hoeper MM, Holt S, Klose H, Krüger S, Lange TJ, Reichenberger F, Skowasch D, Ulrich S, Wilkens H, Seeger W.

Dtsch Med Wochenschr. 2016 Oct;141(S 01):S57-S61. Epub 2016 Oct 19. German.

PMID:
27760451
30.

Why we should care about the mysteries of pulmonary hypertension.

Olschewski H.

Pulm Circ. 2016 Sep;6(3):249-50. doi: 10.1086/687367. No abstract available.

31.

Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension.

Nagaraj C, Tang B, Nagy BM, Papp R, Jain PP, Marsh LM, Meredith AL, Ghanim B, Klepetko W, Kwapiszewska G, Weir EK, Olschewski H, Olschewski A.

Eur Respir J. 2016 Oct;48(4):1127-1136. doi: 10.1183/13993003.01814-2015. Epub 2016 Aug 18.

32.

Counter-clockwise vortical blood flow in the main pulmonary artery in a patient with patent ductus arteriosus with pulmonary arterial hypertension: a cardiac magnetic resonance imaging case report.

Reiter G, Reiter U, Kovacs G, Adelsmayr G, Greiser A, Stalder AF, Olschewski H, Fuchsjäger M.

BMC Med Imaging. 2016 Aug 8;16(1):45. doi: 10.1186/s12880-016-0150-z.

33.

TASK-1 Regulates Apoptosis and Proliferation in a Subset of Non-Small Cell Lung Cancers.

Leithner K, Hirschmugl B, Li Y, Tang B, Papp R, Nagaraj C, Stacher E, Stiegler P, Lindenmann J, Olschewski A, Olschewski H, Hrzenjak A.

PLoS One. 2016 Jun 13;11(6):e0157453. doi: 10.1371/journal.pone.0157453. eCollection 2016.

34.

Does exercise pulmonary hypertension exist?

Lau EM, Chemla D, Whyte K, Kovacs G, Olschewski H, Herve P.

Curr Opin Pulm Med. 2016 Sep;22(5):400-7. doi: 10.1097/MCP.0000000000000292. Review.

PMID:
27270182
35.

Automated integer programming based separation of arteries and veins from thoracic CT images.

Payer C, Pienn M, Bálint Z, Shekhovtsov A, Talakic E, Nagy E, Olschewski A, Olschewski H, Urschler M.

Med Image Anal. 2016 Dec;34:109-122. doi: 10.1016/j.media.2016.05.002. Epub 2016 May 6.

PMID:
27189777
36.

[Research in Austria - the Ludwig Boltzmann Institute for Lung Vascular Research].

Kovacs G, Kleinschek D, Kwapiszewska G, Bálint Z, Olschewski H, Olschewski A.

Pneumologie. 2016 May;70(5):331-5. doi: 10.1055/s-0042-104767. Epub 2016 May 11. Review. German.

PMID:
27168041
37.

Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.

Behr J, Bendstrup E, Crestani B, Günther A, Olschewski H, Sköld CM, Wells A, Wuyts W, Koschel D, Kreuter M, Wallaert B, Lin CY, Beck J, Albera C.

Lancet Respir Med. 2016 Jun;4(6):445-53. doi: 10.1016/S2213-2600(16)30044-3. Epub 2016 May 5.

PMID:
27161257
38.

Native myocardial T1 mapping in pulmonary hypertension: correlations with cardiac function and hemodynamics.

Reiter U, Reiter G, Kovacs G, Adelsmayr G, Greiser A, Olschewski H, Fuchsjäger M.

Eur Radiol. 2017 Jan;27(1):157-166. Epub 2016 Apr 27.

39.

Functional and molecular factors associated with TAPSE in hypoxic pulmonary hypertension.

Crnkovic S, Schmidt A, Egemnazarov B, Wilhelm J, Marsh LM, Ghanim B, Klepetko W, Olschewski A, Olschewski H, Kwapiszewska G.

Am J Physiol Lung Cell Mol Physiol. 2016 Jul 1;311(1):L59-73. doi: 10.1152/ajplung.00381.2015. Epub 2016 Apr 22.

40.

CD133+ cells in pulmonary arterial hypertension.

Foris V, Kovacs G, Marsh LM, Bálint Z, Tötsch M, Avian A, Douschan P, Ghanim B, Klepetko W, Olschewski A, Olschewski H.

Eur Respir J. 2016 Aug;48(2):459-69. doi: 10.1183/13993003.01523-2015. Epub 2016 Apr 21.

41.

Pulmonary arterial pressure in patients with myelodysplastic syndromes.

Sill H, Kqiku-Kryeziu X, Avian A, Kovacs G, Gaal S, Zebisch A, Olschewski H.

Leuk Lymphoma. 2016 Nov;57(11):2723-6. doi: 10.3109/10428194.2016.1160086. Epub 2016 Apr 15. No abstract available.

PMID:
27082148
42.

[Pulmonary (Arterial) Hypertension].

Kwapiszewska G, Hoffmann J, Kovacs G, Stacher E, Olschewski A, Olschewski H.

Pneumologie. 2016 Oct;70(10):630-637. Epub 2016 Apr 6. Review. German.

PMID:
27050448
43.

Efficacy and Safety of Inhaled Iloprost in Japanese Patients With Pulmonary Arterial Hypertension - Insights From the IBUKI and AIR Studies.

Saji T, Myoishi M, Sugimura K, Tahara N, Takeda Y, Fukuda K, Olschewski H, Matsuda Y, Nikkho S, Satoh T.

Circ J. 2016;80(4):835-42. doi: 10.1253/circj.CJ-16-0097. Epub 2016 Mar 18.

44.

[Pulmonary embolism and direct oral anticoagulants].

Olschewski H.

Wien Med Wochenschr. 2018 Apr;168(5-6):144-147. doi: 10.1007/s10354-016-0449-y. Epub 2016 Mar 16. Review. German.

PMID:
26983621
45.

Letter by Olschewski et al Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation".

Olschewski A, Chandran N, Olschewski H.

Circulation. 2016 Mar 15;133(11):e439. doi: 10.1161/CIRCULATIONAHA.115.018800. No abstract available.

46.

Amitriptyline and carbamazepine utilize voltage-gated ion channel suppression to impair excitability of sensory dorsal horn neurons in thin tissue slice: An in vitro study.

Wolff M, Czorlich P, Nagaraj C, Schnöbel-Ehehalt R, Li Y, Kwapiszewska G, Olschewski H, Heschl S, Olschewski A.

Neurosci Res. 2016 Aug;109:16-27. doi: 10.1016/j.neures.2016.02.006. Epub 2016 Mar 2.

PMID:
26945616
47.

Proposed new definition of exercise pulmonary hypertension decreases false-positive cases.

Kovacs G, Avian A, Olschewski H.

Eur Respir J. 2016 Apr;47(4):1270-3. doi: 10.1183/13993003.01394-2015. Epub 2016 Jan 7. No abstract available.

48.

Clinical Manifestations of Respiratory Bronchiolitis as an Incidental Finding in Surgical Lung Biopsies: A Retrospective Analysis of a Large Austrian Registry.

Scheidl SJ, Kusej M, Flick H, Stacher E, Matzi V, Kovacs G, Popper HH, Costabel U, Olschewski H.

Respiration. 2016;91(1):26-33. doi: 10.1159/000442053. Epub 2015 Dec 12.

49.

[ESC guidelines 2015 on pulmonary hypertension].

Olschewski H, Kovacs G; European Society of Cardiology; European Respiratory Society.

Herz. 2015 Dec;40(8):1055-60. doi: 10.1007/s00059-015-4381-5. German.

PMID:
26626554
50.

Sleep Related Breathing Disorders and Inflammation - The Missing Link? A Cohort Study Evaluating the Interaction of Inflammation and Sleep Related Breathing Disorders and Effects of Treatment.

Troester N, Palfner M, Schmidberger E, Olschewski H, Avian A.

PLoS One. 2015 Sep 10;10(9):e0137594. doi: 10.1371/journal.pone.0137594. eCollection 2015.

Supplemental Content

Loading ...
Support Center